Most studies have reported higher percentage of estrogen receptor (ER)-positive/progesterone receptor (PR)-positive tumors among SDBC leading to a higher prevalence of luminal A and a lower prevalence of triple negative (TN) breast carcinomas in this group of tumors [4,9,10,11]. The gene discussed is ESR1; the disease is breast carcinoma.